Prevention of negative symptom psychopathologies in first-episode schizophrenia

被引:147
|
作者
Melle, Ingrid [1 ,4 ]
Larsen, Tor K. [5 ,6 ]
Haahr, Ulrik [7 ]
Friis, Svein [1 ,4 ]
Johannesen, Jan O. [5 ]
Opjordsmoen, Stein [1 ,4 ]
Rund, Bjorn R. [2 ,8 ]
Simonsen, Erik [7 ,9 ]
Vaglum, Per [3 ]
McGlashan, Thomas [10 ]
机构
[1] Univ Oslo, Inst Psychiat, Fac Med, N-0316 Oslo, Norway
[2] Univ Oslo, Inst Psychol, Fac Social Sci, N-0316 Oslo, Norway
[3] Univ Oslo, Dept Behav Sci Med, N-0316 Oslo, Norway
[4] Ullevaal Univ Hosp, Dept Psychiat, Oslo, Norway
[5] Stavanger Univ Hosp, Div Psychiat, Stavanger, Norway
[6] Univ Bergen, Psychiat Sect, Dept Clin Med, N-5020 Bergen, Norway
[7] Zealand Reg Psychiat, Psychiat Res Unit, Roskilde, Denmark
[8] Asker & Baerum Hosp Trust, Sandvika, Norway
[9] Univ Copenhagen, Inst Psychiat, Copenhagen, Denmark
[10] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA
关键词
D O I
10.1001/archpsyc.65.6.634
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: The duration of untreated psychosis (DUP)-the time from onset of psychotic symptoms to the start of adequate treatment-is consistently correlated with better course and outcome, but the mechanisms are poorly understood. Objective: To report the effects of reducing DUP on 2-year course and outcome. Design: A total of 281 patients with a DSM-IV diagnosis of nonorganic, nonaffective psychosis coming to their first treatment during 4 consecutive years were recruited, of which 231 participated in the 2-year follow-up. A comprehensive early detection (ED) system, based on public information campaigns and low-threshold-psychosis-detecting teams, was introduced in 1 health care area (ED area), but not in a comparable area (no-ED area). Both areas ran equivalent 2-year treatment programs. Results: First-episode patients from the ED area had a significantly lower DUP, better clinical status, and milder negative symptoms at the start of treatment. There were no differences in treatment received for the first 2 years between the groups. The difference in negative symptoms was maintained at the 1-year follow-up. There was a statistically significant difference in the Positive and Negative Syndrome Scale negative component, cognitive component, and depressive component in favor of the ED group at the 2-year follow-up. Multiple linear regression analyses gave no indication that these differences were due to confounders. Conclusion: Reducing the DUP has effects on the course of symptoms and functioning, including negative symptoms, suggesting secondary prevention of the negative psychopathologies in first-episode schizophrenia.
引用
收藏
页码:634 / 640
页数:7
相关论文
共 50 条
  • [1] Cognitive and negative symptom improvements with treatment in first-episode schizophrenia are interrelated
    Schuepbach, D
    Keshavan, MS
    Kmiec, JA
    Sweeney, JA
    [J]. BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 175S - 175S
  • [2] The trajectories and correlates of two negative symptom subdomains in first-episode schizophrenia
    Phahladira, Lebogang
    Asmal, Laila
    Luckhoff, Hilmar K.
    du Plessis, Stefan
    Scheffler, Freda
    Smit, Retha
    Chiliza, Bonginkosi
    Emsley, Robin
    [J]. SCHIZOPHRENIA RESEARCH, 2022, 243 : 17 - 23
  • [3] Symptom and demographic profiles in first-episode schizophrenia
    Gelber, EI
    Kohler, CG
    Bilker, WB
    Gur, RC
    Brensinger, C
    Siegel, SJ
    Gur, RE
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (2-3) : 185 - 194
  • [4] Seasonality of symptom onset in first-episode schizophrenia
    Owens, N
    McGorry, PD
    [J]. PSYCHOLOGICAL MEDICINE, 2003, 33 (01) : 163 - 167
  • [5] USING RASCH ANALYSIS TO IDENTIFY NEGATIVE SYMPTOM RESPONSE TRAJECTORIES IN FIRST-EPISODE SCHIZOPHRENIA
    Baandrup, Lone
    Nielsen, Mette Odegaard
    Allerup, Peter
    Sorensen, Mikkel
    Glenthoj, Birte
    [J]. SCHIZOPHRENIA BULLETIN, 2019, 45 : S116 - S116
  • [6] Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
    Gao, Zhiyong
    Xiu, Meihong
    Liu, Jiahong
    Wu, Fengchun
    Zhang, Xiang-Yang
    [J]. SCHIZOPHRENIA, 2023, 9 (01)
  • [7] Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
    Zhiyong Gao
    Meihong Xiu
    Jiahong Liu
    Fengchun Wu
    Xiang-Yang Zhang
    [J]. Schizophrenia, 9
  • [8] Symptom attribution and frontal cortical thickness in first-episode schizophrenia
    Asmal, Laila
    du Plessis, Stefan
    Vink, Matthijs
    Chiliza, Bonginkosi
    Kilian, Sanja
    Emsley, Robin
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2018, 12 (04) : 652 - 659
  • [9] Family interventions and prevention of suicide in first-episode schizophrenia
    Sher, L.
    Kahn, R. S.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2019, 139 (05) : 484 - 484
  • [10] First-episode schizophreniform disorder: comparisons with first-episode schizophrenia
    Zarate, CA
    Tohen, M
    Land, ML
    [J]. SCHIZOPHRENIA RESEARCH, 2000, 46 (01) : 31 - 34